Objective: To investigate whether a novel compound heterozygous mutations c.257C>G (p.T86R)/c.176del16 (p.G59A fs*18) in GJB2 result in hearing loss.
| INTRODUC TI ON
To our knowledge, there are at least more than 134 genetic loci and 80 different genes identified to associate with sensorineural hearing loss (SNHL), one of the most common human sensory disorders CX26, is one type of the Gap junctions most frequently involved in autosomal recessive nonsyndromic hearing loss in some population. 3, 4 As a key factor, it has been proposed to play an important role in the recycling of the K + ion between the endolymph and perilymph. 5 CX26
is located in the fibrocytes of spiral ligaments and limbi, basal cells of striavascularis, and all types of supporting cells in the organ of Corti.
The encoded gene of CX26 is known as GJB2, which could be responsible for most autosomal recessive nonsyndromic phenotype hearing loss and tend to be prelingual, [6] [7] [8] but some autosomal dominant transmission mutations in GJB2 gene tend to be postlingual, progressive, and associated with some other syndromic phenotype [9] [10] [11] (http:// davinci.crg.es/ deafness). Currently, the most common GJB2 mutations were identified, including c.35delG, c.167del16, and c.235delC.
These mutations have been demonstrated to responsible for the hearing loss identified among different populations. [12] [13] [14] [15] [16] [17] In this study, we report that a novel compound heterozygote mutation in the GJB2 gene has been identified successfully.
Furthermore, its pathogenic impacts on hearing function were also evaluated via bioinformatic structural analysis and subcellular localization in HEK293 and primary SGN cells.
| MATERIAL S AND ME THODS

| Clinical analysis
All individuals in this family were examined by auditory brainstem responses (ABRs) testing. Their medical histories were obtained by using of a questionnaire according to the aspects of this condition followed: medication, noise exposure, pathological changes in the ear, and other relevant clinical manifestations. The study was approved by Research Ethics Committee of Xuzhou medical University.
| Auditory brainstem responses (ABRs) evaluations
ABRs were tested by using of the IHS System (Intelligent Hearing System, Smart EP, FL, USA) and ER-3A insert earphone. The buttonshaped electrode was placed on the skin: the recording electrode was placed on the middle of the top of the forehead, the reference electrodes were placed on both earlobes (or mastoid), and the ground electrode was placed at the nasion. The 100-μs clicks were presented at a repetition rate of 19.3/s at a bandpass of 100-3000 Hz. The sweeps were typically 1.024 seconds. The maximum output level for the clicks was 100 dB nHL. The threshold of ABR was defined as the minimum sound intensity to evoke repeatable wave V. When there was no response or absent waveforms at 90 dB nHL, the subjects were tested with 95 and 100 dB nHL.
| Genotyping analysis
We isolated Genomic DNA from EDTA-anticoagulated blood samples of the five siblings and their parents by using blood DNA Isolation kits (Tiangen, china). Nine hotspot mutations of deafness genes present in Chinese populations were screened by using a universal array approach, termed a multiplex allele-specific PCR-based universal array (ASPUA), as previously described. 18, 19 Each blood DNA samples were further examined by sequencing.
| Molecular dynamics simulation
Molecular dynamics (MD) simulation of the two systems was carried out using AMBER 12 molecular simulation package with the standard AMBER03 force field (ff03). 20 Each system was immersed in a rectangular box of TIP3P water molecules, which extended 12 Å away from any solute atoms. To neutralize the systems, appropriate numbers of Na + were added. Each system was firstly energy minimizing using the sander program in AMBER 12 via the following three steps: the water molecules and ions were firstly optimized by restraining the protein (2500 cycles of steepest descent minimization and 2500 cycles of conjugated gradient minimization); Secondly, the side chains of the protein were relaxed by restraining all backbone atoms (2500 cycles of steepest descent minimization and 2500 cycles of conjugated gradient minimization); finally, the whole system was relaxed without any restrain (5000 cycles of steepest descent minimization and 5000 cycles of conjugated gradient minimization). After energy minimization, each system was gradually heated in the NVT ensemble from 0 to 300 K within 60 ps. For the production run, a 10-ns MD simulation with a time step of 2.0 fs was performed under a constant temperature of 300 K. During MD simulation, the SHAKE procedure and particle mesh Ewald (PME) were employed to constrain all bonds involving at least one hydrogen atom and deal with the long-range electrostatic interactions, respectively.
| Cells culture
HEK293 cells were obtained from ATCC (Manassas, VA, USA). 293T cells were maintained in Dulbecco's minimum essential medium (DMEM, Gibco), supplemented with 10% FBS, 100 mg/mL penicillin and 100 mg/mL streptomycin in a humidified atmosphere containing 5% CO 2 at 37°C. Primary SGN cells preparations have been done as previous study. To explore a possible causive mutations, we sequenced the coding exon of GJB2 genes of each member in this family and found a compound heterozygote mutations in GJB2 c.257C>G (p.T86R)/ c.176del16 (p.G59A fs*18) in the four children who showed a profound hearing loss ( Figure 1D ). In comparison, the father and mother showed GJB2-WT/GJB2 c.257C>G (p.T86R) and GJB2-WT/ c.176del16 (p.G59A fs*18), respectively.
| Compound heterozygous mutations in GJB2 genec.257C>G (p.T86R)/c.176del16 (p.G59A fs*18) disrupt formation of CX26 hexamer
Here, a 3D model for the structural analysis of WT/Mut CX26 proteins was built to illustrate the possible mechanism underlying the mutant CX26 induce hearing impairment. We found that the functional gap junction structure, also named as hexamer, is composed of six WT-CX26 mono molecules ( Figure 2A ). As we know, normal formation of hexamer depends on hydrophobic interaction between adjacent CX26 molecules. However, the MD simulation revealed that the Mut-CX26 protein (p.T86R) alters spatial structure of the dimerization, especially in the residues of three amino acids, namely Leu27, Ile185, and Leu187 due to that the side chain residues of arginine in the 86 th mutated CX26 (p.T86R) are longer than threonine 
| GJB2 c.257C>G (p.T86R)/c.176del16 (p.G59A fs*18) alter membrane locatization of CX26 protein
In this study, HEK 293 cells were infected by lenti-virus carrying GFP tagged WT or Mut (257C>G or 176del16) GJB2 respectively, which allowed us to track the intracellular location of CX26. WT-CX26
has been found to form a massive focis located in cell membrane 
| D ISCUSS I ON
Our study demonstrates that compound heterozygous mutation c.257C>G (p.T86R)/c.176del16 (p.G59A fs*18) in the GJB2 gene is F I G U R E 2 3D structures analysis of potential pathogenic mechanism underlying mutant CX26 proteins using MD simulation. A: Hemichannels structure of normal gap junctions composed of six CX26 mono molecules. B: Molecular structure of WT (green) and c.257C>G (p.T86R) (yellow) mutated CX26 proteins. Enlarged area (black circle indicated) highlights the major changes in Leu27, Ile185, and Leu187 in interface of adjacent CX26 mono molecules. Red arrow shows that once the 86th amino acids are changed to be Arg, their side chains will consequently alter and tend to be longer than that of structure which 86th amino acids are Thr. C: Evaluation of the distance between core carbon atom of Thr or Arg and crew carbon atom of corresponding amino acids (Leu27,Ile185 and Leu187) in adjacent CX26 molecules, suggesting a structural alterations between WT CX26 (left) and the c.257C>G (p.T86R) mutated CX26 protein (right) novel, further, the mutation is identified in a Chinese family in which 4 siblings are confirmed to have profound hearing loss carrying this compound heterozygous mutation. It is not consistent with their parents who are diagnosed with normal hearing which indicating an autosomal recessive inheritance pattern. Moreover, our study dem-
onstrates that the compound mutations may lead to the profound hearing loss occurred in this family. In addition, cell study and analysis of molecular dynamics simulation reveal significant influence that compound heterozygous mutation CX26 p.T86R (GJB2 c.257C>G)/ CX26 p.G59Afs*18 (GJB2 c.176del16) could lead to an alterations of subcellular localization which has been confirmed corresponding to the susceptibility of hearing disorder.
Currently, mutations in GJB2 are considered as one of the major causes of nonsyndromic hearing loss following by a dominant or recessive inheritance pattern. [17] [18] [19] The effects of these mutations on the function of CX26 protein could be various and depend on the different positions and types of amino acid substitution. Previous studies proposed that hemichannels structure (hexmer) is crucial for the smooth function of ion channels in the WT-CX26 protein.
Considering that GJB2 c.257C>G (p.T86R) may serve a rare mutation in the second transmembrane domain of the CX26 protein and could be able to convert an uncharged amino acid (threonine) at codon 86 into a positively charged structure (arginine), and logically, it is possible that the rare mutation may cause a functional null protein. 19 Our study showed that the steric hindrance became greater as a result that threonine has been replaced by arginine (Figure 2 in GJB2 gene are never identified and proposed before this study.
Moreover, it is the first report to show how the compound heterozygous mutations disrupt the function of CX26 protein by using of both investigations of cellular biology and MD simulations; therefore, this study still presents a clinical value for further genetic screening of hearing disorder.
| CON CLUS ION
Here, we demonstrate that the c.257C>G (p.T86R)/c.176del16
(p.G59A fs*18) compound mutations in the GJB2 gene are novel, and the mutations are identified in a Chinese family. Furthermore, we demonstrate that the mutations are pathogenicity and may highly lead to a profound hearing loss. Thus, our study could provide a clinical value for genetic screening in further application. 
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